Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Eric Roeland

    TitleAssistant Clinical Professor
    SchoolUniversity of California, San Diego
    Address3855 Health Sciences Drive #0987
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California San DiegoHematology/Oncology FellowshipMedicine2012
      San Diego Hospice & The Institute for Palliative MedicineHospice & Palliative Medicine Fellowship2009
      University of California San DiegoInternship & ResidencyMedicine2008
      University of Colorado Health Sciences CenterDoctor of MedicineSchool of Medicine2005
      Northwestern UniversityBachelor of ArtsWeinberg College of Arts & Sciences2000
      Collapse Awards and Honors
      San Diego County Medical Society2015San Diego’s 2015 Top Doctors Hospice & Palliative Medicine
      American Academy of Hospice & Palliative Medicine2015Inspirational Leader Under 40 Award
      Massachusetts General Hospital2015Workshop on Methods in Supportive Oncology
      American Society of Clinical Oncology/American Association Cancer Research2015Vail Workshop Methods in Clinical Cancer Research
      American Academy of Hospice & Palliative Medicine2015Fellow of the Academy
      American Academy of Hospice & Palliative Medicine2014Kathleen Foley Palliative Care Research Scholars Award
      University of California San Diego2013National Center of Leadership in Academic Medicine
      American Society of Clinical Oncology2011Travel Scholar

      Collapse Overview 
      Collapse Overview
      Research Interests
      As an oncologist and palliative medicine physician, Dr. Roeland is committed to finding more effective solutions for improving the quality of care for cancer patients. He is committed to the integration of cancer treatment with optimal symptom management. His current research is primarily focused on symptom intervention clinical trials across the entire spectrum of cancer. Ultimately, he wants to promote a new standard for cancer care – simultaneous integrated oncology and palliation.

      Topics include:
      -Cancer pain
      -Chemotherapy-induced nausea and vomiting
      -Anorexia cachexia

      Principal Investigator, UCSD Moores Cancer Center, Supportive Oncology Trials

      Open Studies
      -A Prospective Pilot Study to Correlate Cross-Sectional Computed Tomography Skeletal Muscle Loss with Functional Activity in Metastatic Gastrointestinal and Lung Cancer Patients
      -A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients (NCT02745353)
      -Alliance A221303: Early Palliative Care in Metastatic Gastrointestinal and Lung Cancer Patients (NCT02349412)
      - Single-Center, Prospective Expansion Study Evaluating Advance Care Planning Discussions Utilizing Novel Approach

      Completed Studies
      -Vector Oncology ALSSCINV1305: Observational Study of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Multiday Highly Emetogenic Chemotherapy (HEC) Regimens for Hematological Malignancies
      -Xbiotech 2012-PT023: A Pivotal Phase III Study to Evaluate Overall Survival using MABp1 as a Monotherapy in Metastatic Colorectal Cancer Patients with Cachexia
      -Lilly I3S-MC-JABA: A Phase I Safety Study of LY2787106 in Patients with Cancer and Anemia
      -Lilly I1Q-MC-JDDG: A Randomized Phase II Placebo-Controlled Study of LY2495655 in Patients with Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy.
      -PledPharma PP095: A Double Blind Randomized Three Armed Phase II Trial of Pledox in Two Different Doses in Combination with FOLFOX6 compared to Placebo + FOLFOX6 in Patients with Advanced Metastatic Colorectal (Stage IV) Cancer (PLIANT Study)
      -Merck V212-011: A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
      -Helsinn HT-ANAM-301: Anamorelin HcL in the Treatment of Non-Small Cell Lung Cancer Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HcL in Patients with NSCLC-C (ROMANA 1)

      Collapse Interests
      rectal cancer, cholangiocarcinoma, colon cancer, gastric cancer, esophageal cancer, pancreatic cancer, advance care planning, supportive care, end-of-life care, fatigue, neuropathy, diarrhea, constipation, vomiting, nausea, pain, cachexia, cancer, symptoms, palliative care

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse Featured Videos
      Collapse Featured Presentations
      Collapse Faculty Mentoring
      Collapse Twitter
      Collapse In The News

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer Cachexia: Beyond Weight Loss. J Oncol Pract. 2016 Nov; 12(11):1163-1171. PMID: 27858548.
        View in: PubMed
      2. Roeland EJ, Ma JD, Nelson SH, Seibert T, Heavey S, Revta C, Gallivan A, Baracos VE. Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials. Support Care Cancer. 2017 Feb; 25(2):365-369. PMID: 27628947.
        View in: PubMed
      3. Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. J Natl Compr Canc Netw. 2016 Apr; 14(4):439-45. PMID: 27059192.
        View in: PubMed
      4. Roeland EJ, LeBlanc TW. Palliative chemotherapy: oxymoron or misunderstanding? BMC Palliat Care. 2016; 15(1):33. PMID: 27000049.
        View in: PubMed
      5. Ma JD, Benn M, Nelson SH, Campillo A, Heavey SF, Cramer A, Revta C, Thornberry K, Roeland EJ. Exploring the Definition of an Informed Health Care Proxy. J Palliat Med. 2016 Mar; 19(3):250-1. PMID: 26836962.
        View in: PubMed
      6. Roeland E, Ku G. Spanning the canyon between stem cell transplantation and palliative care. Hematology Am Soc Hematol Educ Program. 2015 Dec 5; 2015(1):484-9. PMID: 26637762.
        View in: PubMed
      7. Gramling R, Stanek S, Ladwig S, Gajary-Coots E, Cimino J, Anderson W, Norton SA. Feeling Heard and Understood: A Patient-Reported Quality Measure for the Inpatient Palliative Care Setting. J Pain Symptom Manage. 2016 Feb; 51(2):150-4. PMID: 26596879.
        View in: PubMed
      8. Roeland E. Guiding Principles in the Management of Chemotherapy-Induced Nausea and Vomiting. Clin Adv Hematol Oncol. 2015 Oct; 13(10 Suppl 10):3-5. PMID: 26859507.
        View in: PubMed
      9. Roeland E, Schwartzberg LS, Aapro MS. Q&A. Clin Adv Hematol Oncol. 2015 Oct; 13(10 Suppl 10):12-3. PMID: 26859510.
        View in: PubMed
      10. Montross-Thomas LP, Irwin SA, Meier EA, Gallegos JV, Golshan S, Roeland E, McNeal H, Munson D, Rodseth L. Enhancing legacy in palliative care: study protocol for a randomized controlled trial of Dignity Therapy focused on positive outcomes. BMC Palliat Care. 2015; 14(1):44. PMID: 26391775.
        View in: PubMed
      11. Chang A, Roeland EJ, Atayee RS, Revta C, Ma JD. Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care. J Pain Palliat Care Pharmacother. 2015 Sep; 29(3):247-60. PMID: 26368648.
        View in: PubMed
      12. Lin KJ, Ching A, Edmonds KP, Roeland EJ, Revta C, Ma JD, Atayee RS. Variable Patterns of Continuous Morphine Infusions at End of Life. J Palliat Med. 2015 Sep; 18(9):786-9. PMID: 26107143.
        View in: PubMed
      13. Langley-DeGroot M, Ma JD, Hirst J, Roeland EJ. Olanzapine in the Treatment of Refractory Nausea and Vomiting: A Case Report and Review of the Literature. J Pain Palliat Care Pharmacother. 2015 Jun; 29(2):148-52. PMID: 26095486.
        View in: PubMed
      14. Bruggeman AR, Heavey SF, Ma JD, Revta C, Roeland EJ. Lack of documentation of evidence-based prognostication in cancer patients by inpatient palliative care consultants. J Palliat Med. 2015 Apr; 18(4):382-5. PMID: 25608220.
        View in: PubMed
      15. Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer. 2015 Aug; 23(8):2231-44. PMID: 25564221.
        View in: PubMed
      16. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90(1):224-30. PMID: 25195994.
        View in: PubMed
      17. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. PMID: 25145504.
        View in: PubMed
      18. Amin P, Roeland E, Atayee R. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain. J Pain Palliat Care Pharmacother. 2014 Sep; 28(3):233-42. PMID: 25102039.
        View in: PubMed
      19. Heavey SF, Roeland EJ, Tipps AM, Datnow B, Sicklick JK. Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol. 2014 Aug; 5(4):E58-64. PMID: 25083307.
        View in: PubMed
      20. Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, Le QT, Murphy JD. Palliative Radiation Before Hospice: The Long and the Short of It. J Pain Symptom Manage. 2014 May 10. PMID: 24819083.
        View in: PubMed
      21. Ma JD, Heavey SF, Revta C, Roeland EJ. Novel investigational biologics for the treatment of cancer cachexia. Expert Opin Biol Ther. 2014 Aug; 14(8):1113-20. PMID: 24707881.
        View in: PubMed
      22. Roeland E, Cain J, Onderdonk C, Kerr K, Mitchell W, Thornberry K. When open-ended questions don't work: the role of palliative paternalism in difficult medical decisions. J Palliat Med. 2014 Apr; 17(4):415-20. PMID: 24588626.
        View in: PubMed
      23. Wong-Sefdan I, Ale-Ali A, DeMoor PA, Martinez S, Curtin P, Lane T, Roeland E. Implementing inpatient, evidence-based, antihistamine-transfusion premedication guidelines at a single academic US hospital. J Community Support Oncol. 2014 Feb; 12(2):56-64. PMID: 24971406.
        View in: PubMed
      24. Ma JD, Horton JM, Hwang M, Atayee RS, Roeland EJ. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients. J Pain Palliat Care Pharmacother. 2014 Mar; 28(1):4-9. PMID: 24417217.
        View in: PubMed
      25. Hwang M, Pirrello R, Pu M, Messer K, Roeland E. Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital. Support Care Cancer. 2013 Oct; 21(10):2817-24. PMID: 23732621.
        View in: PubMed
      26. Roeland E, Loprinzi C, Moynihan TJ, Smith TJ, Temel J. In chemotherapy for lung cancer, sometimes less is more. J Natl Compr Canc Netw. 2013 Mar 1; 11(3):232-5. PMID: 23486449.
        View in: PubMed
      27. Roeland E, Shimabukuro KA, Fanta PT, Rose SC, Reid TR. Early outcome of a phase II study of yttrium-90 radioactive resin microspheres in the treatment of colorectal adenocarcinoma metastatic to the liver after failure of first-line combination chemotherapy (inSIRT Trial). J Clin Oncol. 2011 Feb; 29(4_suppl):626. PMID: 27985708.
        View in: PubMed
      28. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 2: psychosocial concerns. J Support Oncol. 2010 Jul-Aug; 8(4):179-83. PMID: 20822037.
        View in: PubMed
      29. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms. J Support Oncol. 2010 May-Jun; 8(3):100-16. PMID: 20552923.
        View in: PubMed
      30. Roeland E, von Gunten CF. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009 Jul; 11(4):298-303. PMID: 19508835.
        View in: PubMed
      31. Roeland E. Darkness is no more. J Palliat Med. 2009 Apr; 12(4):389-90. PMID: 19327081.
        View in: PubMed
      Eric's Networks
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Similar People
      People who share similar concepts with this person.
      Physical Neighbors
      People whose addresses are nearby this person.
      Back to TOP